Adenosine-dependent synaptic effects in mouse hippocampal slices
Cell-based study · Acute hippocampal slices from 8–10-week-old C57BL/6J mice, plus global and forebrain-neuronal A2A receptor knockouts. [1]
Theobromine reversibly increased basal transmission but reduced LTP in untreated slices. Adenosine removal and receptor controls support A1-dependent basal facilitation and A2A-dependent LTP modulation. These are functional tissue effects, not direct receptor-binding potency measurements.
| Endpoint | Reported result | Reference |
|---|---|---|
| Basal fEPSP slope change relative to pretreatment baseline | mean ± SEM 34.04 ± 2.80%; p < 0.001 vs baseline (0%); n = 22 | [1] |
| LTP magnitude, control versus theobromine | mean ± SEM 66.99 ± 10.29% vs 24.39 ± 7.03%; p < 0.01; n = 6 | [1] |
| Adenosine and receptor dependence | qualitative ADA (2 U/mL) occluded basal facilitation and LTP reduction; DPCPX (100 nM) occluded basal facilitation but did not prevent LTP reduction; A2A deletion preserved basal facilitation but eliminated significant LTP reduction. | [1] |
| LTP with SCH58261 alone versus SCH58261 plus theobromine | mean ± SEM 13.31 ± 3.74% vs 51.22 ± 7.72%; p < 0.05; n = 3–6 | [1] |
Literature-Reported Treatment Conditions
- Treatment concentration
- 30 μM theobromine
- Exposure duration
- Basal effects assessed at 25–30 min; LTP quantified 50–60 min after induction.
- Method
- Bath superfusion of acute hippocampal slices.
- Vehicle
- Fresh aqueous stock diluted into ACSF; residual DMSO from antagonists controlled.
- Co-treatment
- Separate mechanistic comparisons with ADA 2 U/mL, DPCPX 100 nM or SCH58261 50 nM.
- Reported limits
- Captions and Methods disagree on induction frequency; exact stimulation frequency is not adopted. Global-knockout LTP n differs between text and caption; no exact knockout counts/means adopted.
Methods and source locations
Compound reported in the paper: Theobromine; Compound label in the paper: theo
Isolated mouse tissue or cells; no clinical efficacy established.
Results 2.1–2.4; Figures 1–5; Methods 4.2–4.4, 4.7
Basal fEPSP slope change relative to pretreatment baseline: Extracellular Schaffer fiber–CA1 recording; average 25–30 min after application. — Results 2.1; Figure 1B,C; Methods 4.4, 4.7
LTP magnitude, control versus theobromine: fEPSP slope change 50–60 min after induction relative to pre-induction baseline; comparison in different slices from the same animal. — Results 2.1; Figure 1D,E; Methods 4.4, 4.7
Adenosine and receptor dependence: Modifier-alone, control and knockout comparisons. — Results 2.2–2.4; Figures 2, 3, 5
LTP with SCH58261 alone versus SCH58261 plus theobromine: A2A antagonist SCH58261 (50 nM); adding theobromine increased LTP relative to SCH58261 alone. — Results 2.4; Figure 4C,D